Efficacy News and Research

RSS
Diverted medical marijuana use more common among adolescents in substance abuse treatment

Diverted medical marijuana use more common among adolescents in substance abuse treatment

Traditional cures provide economic benefits

Traditional cures provide economic benefits

New drug shows promise for Long QT syndrome

New drug shows promise for Long QT syndrome

FDA grants Senesco's SNS01-T orphan-drug designation to treat lymphomas

FDA grants Senesco's SNS01-T orphan-drug designation to treat lymphomas

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Advaxis reports continued positive patient survival pattern in ADXS-HPV Phase 2 cervical cancer trial

Advaxis reports continued positive patient survival pattern in ADXS-HPV Phase 2 cervical cancer trial

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

New platform for detecting substandard and counterfeit medicines using microfluidics

New platform for detecting substandard and counterfeit medicines using microfluidics

Navidea announces results from Lymphoseek Phase 3 trial on head and neck squamous cell carcinoma

Navidea announces results from Lymphoseek Phase 3 trial on head and neck squamous cell carcinoma

Uroplasty first quarter global sales increase 20% to $5.6 million

Uroplasty first quarter global sales increase 20% to $5.6 million

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

LPL deficiency treatment poised to be first gene therapy in Europe

LPL deficiency treatment poised to be first gene therapy in Europe

Insomnia: an interview with Dr Darryle Schoepp

Insomnia: an interview with Dr Darryle Schoepp

Multi-center clinical trial results demonstrate safety and efficacy of carfilzomib for multiple myeloma

Multi-center clinical trial results demonstrate safety and efficacy of carfilzomib for multiple myeloma

Bard completes enrollment in Lutonix DCB clinical trial for peripheral arterial disease

Bard completes enrollment in Lutonix DCB clinical trial for peripheral arterial disease

CytRx commences aldoxorubicin plus doxorubicin Phase 1b trial in advanced solid tumors

CytRx commences aldoxorubicin plus doxorubicin Phase 1b trial in advanced solid tumors

Healthcare system perceptions predict PSA screening uptake

Healthcare system perceptions predict PSA screening uptake

Regeneron reports total revenues of $304 million for second quarter 2012

Regeneron reports total revenues of $304 million for second quarter 2012

Human neutrophil peptide 1 effectively prevents HIV entry into cells in multiple ways

Human neutrophil peptide 1 effectively prevents HIV entry into cells in multiple ways

NBTI participates in ICT-107 phase II trial for glioblastoma multiforme

NBTI participates in ICT-107 phase II trial for glioblastoma multiforme

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.